Log In
Print
BCIQ
Print
Print this Print this
 

ixazomib (MLN9708)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOral proteasome inhibitor
Molecular Target Proteasome
Mechanism of ActionProteasome inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today